Opening book details…
About this book
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster by Chaitanya Kurhade & Jing Zou & Hongjie Xia & Mingru Liu & Hope C. Chang & Ping Ren & Xuping Xie & Pei‐Yong Shi is a book available to read on EtoBox.
- Author
- Chaitanya Kurhade & Jing Zou & Hongjie Xia & Mingru Liu & Hope C. Chang & Ping Ren & Xuping Xie & Pei‐Yong Shi
- Publisher
- Springer US
- Published
- 2023
- Language
- EN
More by Chaitanya Kurhade & Jing Zou & Hongjie Xia & Mingru Liu & Hope C. Chang & Ping Ren & Xuping Xie & Pei‐Yong Shi
Similar books
- Bivalent SARS-CoV-2 mRNA Vaccines Increase Breadth of Neutralization and Protect Against the BA.5 Omicron Variant in Mice — Suzanne M. Scheaffer & Diana Lee & Bradley Whitener & Baoling Ying & Kai Wu & Chieh-Yu Liang & Hardik Jani & Philippa Martin & Nicholas J. Amato & Laura E. Avena & Daniela Montes Berrueta & Stephen D. Schmidt & Sijy O’Dell & Arshan Nasir & Gwo-Yu... (2023)
- Original SARS-CoV-2 Monovalent and Omicron BA.4/BA.5 Bivalent COVID-19 mRNA Vaccines: Phase 2/3 Trial Interim Results — Spyros Chalkias & Jordan L. Whatley & Frank Eder & Brandon Essink & Shishir Khetan & Paul Bradley & Adam Brosz & Nichole McGhee & Joanne E. Tomassini & Xing Chen & Xiaoping Zhao & Andrea Sutherland & Xiaoying Shen & Bethany Girard & Darin K. Edwards &... (2023)
- Real-world COVID-19 Vaccine Effectiveness Against the Omicron BA.2 Variant in a SARS-CoV-2 Infection-naive Population — Jonathan J. Lau & Samuel M. S. Cheng & Kathy Leung & Cheuk Kwong Lee & Asmaa Hachim & Leo C. H. Tsang & Kenny W. H. Yam & Sara Chaothai & Kelvin K. H. Kwan & Zacary Y. H. Chai & Tiffany H. K. Lo & Masashi Mori & Chao Wu & Sophie A. Valkenburg & Gaya K.... (2023)
- Infectiousness of SARS-CoV-2 Breakthrough Infections and Reinfections During the Omicron Wave — Sophia T. Tan & Ada T. Kwan & Isabel Rodríguez-Barraquer & Benjamin J. Singer & Hailey J. Park & Joseph A. Lewnard & David Sears & Nathan C. Lo (2023)
- mRNA-based Seasonal Influenza and SARS-CoV-2 Multicomponent Vaccine in Healthy Adults: a Phase 1/2 Trial — Amanda K. Rudman Spergel & Jintanat Ananworanich & Ruiting Guo & Weiping Deng & Lizbeth Carmona & Kristin Schaefers & Yamuna D. Paila & Boris Kandinov & Charles H. Eger & Melissa Sinkiewicz & Sarah Shao & Carole Henry & Christine A. Shaw (2025)
- SARS-CoV-2 mRNA Vaccine Animal Experiment Report — Pharmaceuticals and Medical Devices Agency (PMDA)